Head/Neck Cancer News

The FDA granted accelerated approval to fam-trastuzumab deruxtecan-nxki for the treatment of adults with unresectable or metastatic HER2-positive solid tumors who received previous systemic therapy and lack additional treatment options.

Lillian L. Siu, MD, FAACR, has been elected American Association for Cancer Research president-elect for 2024-2025.

Most of the major cancer clinical trial centers in the U.S. are located near more affluent and white populations compared with the national average, according to results published in JAMA Oncology.

Cisplatin chemotherapy may not reach its potential efficacy in individuals with head and neck cancer if they are exposed to secondhand smoke, according to results published in the International Journal of Molecular Sciences.

Adults who develop hypoparathyroidism after a total thyroidectomy have an increased risk for all-cause mortality compared with the general population, but only if the indication for their surgery was cancer, according to study data.

Patients with locoregionally advanced nasopharyngeal carcinoma may benefit from radiotherapy alone, result from a randomized phase 3 study suggest.

Compared with expectant management, imaging-based surveillance did not improve outcomes among patients in remission after completion of primary radiation therapy for head and neck cancer, according to data published in JAMA Network Open.

Arya Amini, MD, still remembers sitting on the steps outside of his dean’s office at University of California, Irvine, more than a decade ago, prepared to race inside in case he did not get matched with a radiation oncology residency.

Extended family members of men with severe subfertility or infertility may have an increased risk for several different cancer types, study results published in Human Reproduction showed.

Lymphatic fluid from surgical drains could offer important insights to guide treatment for certain patients with head and neck cancer, according to study results.